美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

IDEAYA Biosciences

40.04

+0.37000.93%

盘后：40.840.8000+2.00%19:59 EDT

成交量：78.68万

成交额：3,156.40万

市值：38.55亿

市盈率：-20.47

高：40.46

开：39.73

低：39.12

收：39.67

52周最高：40.58

52周最低：23.23

股本：9,627.48万

流通股本：9,437.45万

量比：0.88

换手率：0.83%

股息：- -

股息率：- -

每股收益(TTM):-1.9561

每股收益(LYR):-1.2849

净资产收益率：-16.22%

总资产收益率：-11.54%

市净率：3.22

市盈率(LYR):-31.16

数据加载中...

总览公司新闻资讯公告

IDEAYA Biosciences：计划于2026年下半年启动与罗氏RG6505联合治疗的1期临床队列，针对MTAP缺失及RAS突变型胰腺导管腺癌

IDEAYA Biosciences宣布与Genentech达成临床合作，聚焦MTAP缺失型KRAS G12d突变胰腺癌

IDEAYA Biosciences宣布IDE892——有望成为同类最佳MTA协同PRMT5抑制剂——启动MTAP缺失胰腺癌和肺癌1/2期研究第二部分单药扩展阶段

市场快讯——美股行情动态-托尔兄弟、TG Therapeutics、CECO Environmental

市场快讯——美股行情-Nuvalent、Sirius XM、J.M. Smucker

热门话题-IDEAYA生物科技因计划出售3亿美元股票而股价下跌

IDEAYA Biosciences 宣布拟进行高达3亿美元的普通股及预融资权证公开发行

IDEAYA Biosciences宣布与罗氏在MTAP缺失型RAS突变胰腺癌领域达成临床合作

IDEAYA与施维雅在ASCO公布Darovasertib联合疗法一线治疗HLA-A2:01阴性转移性葡萄膜黑色素瘤的2/3期关键试验完整数据

IDEAYA Biosciences公布截至2026年3月31日持有约9.73亿美元现金及证券资金可支撑运营至2030年

IDEAYA Biosciences将于五月启动RTOR申请，新药上市申请预计2026年下半年完成

美国研究综述-百健、Equinix、Revolution Medicines

美国研究综述-百健、Equinix、Revolution Medicines

BUZZ--美国股票走势-Allogene Therapeutics、Adobe、Williams-Sonoma

IDEAYA Biosciences飙涨逾40%！因眼癌药物组合试验达到主要目标并计划提交新药申请

BUZZ-眼癌药物组合在试验中提高了存活率，IDEAYA 生物科学公司股价大涨

IDEAYA与施维雅公布Darovasertib联合克唑替尼一线治疗HLA-A*02:01阴性转移性葡萄膜黑色素瘤的2/3期注册试验（OPTIMUM-02）积极顶线结果

Ideaya眼癌药物达到中后期试验的主要目标

IDEAYA Biosciences计划于2026年下半年提交新药申请支持美国加速审批路径

IDEAYA Biosciences临床试验达到主要终点 BICR评估显示中位无进展生存期实现统计学显著改善

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/IDYA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","market":"US","secType":"STK","nameCN":"IDEAYA Biosciences","latestPrice":40.04,"timestamp":1787601600000,"preClose":39.67,"halted":0,"volume":786770,"hourTrading":{"tag":"盘后","latestPrice":40.84,"preClose":40.04,"latestTime":"19:59 EDT","volume":35484,"amount":1420914.32,"timestamp":1787615990160,"change":0.8,"changeRate":0.01998,"amplitude":0.01998},"delay":0,"changeRate":0.009326947315351585,"floatShares":94374456,"shares":96274800,"eps":-1.956123,"marketStatus":"未开盘","change":0.37,"latestTime":"08-24 16:00:00 EDT","open":39.73,"high":40.46,"low":39.12,"amount":31563996.05358,"amplitude":0.033779,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.956123,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"listingDate":1558584000000,"exchange":"NASDAQ","adjPreClose":39.67,"preHourTrading":{"tag":"盘前","latestPrice":39.82,"preClose":39.67,"latestTime":"09:29 EDT","volume":240,"amount":9538.60008,"timestamp":1787578198439,"change":0.15,"changeRate":0.003781,"amplitude":0.007562},"postHourTrading":{"tag":"盘后","latestPrice":40.84,"preClose":40.04,"latestTime":"19:59 EDT","volume":35484,"amount":1420914.32,"timestamp":1787615990160,"change":0.8,"changeRate":0.01998,"amplitude":0.01998},"volumeRatio":0.87734,"impliedVol":0.9449,"impliedVolPercentile":0.6175},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","floatShares":94374456,"roa":"-11.54%","roe":"-16.22%","lyrEps":-1.284937,"volumeRatio":0.87734,"shares":96274800,"dividePrice":0,"high":40.46,"amplitude":0.033779,"preClose":39.67,"low":39.12,"week52Low":23.23,"pbRate":"3.22","psRate":"16.46","week52High":40.58,"institutionHeld":0,"latestPrice":40.04,"eps":-1.956123,"divideRate":0,"volume":786770,"delay":0,"ttmEps":-1.956123,"open":39.73,"prevYearClose":34.57,"prevWeekClose":39.67,"prevMonthClose":35.5,"prevQuarterClose":37.27,"fiveDayClose":36.54,"twentyDayClose":36.77,"sixtyDayClose":29.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDYA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"IDYA","fiscalQuarterEnding":"2026/06","expectedEps":-1.18,"name":null,"time":"盘前","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-1.22},{"market":"US","date":"2026-05-05","symbol":"IDYA","fiscalQuarterEnding":"2026/03","expectedEps":-1.07,"name":null,"time":"盘前","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-1.11},{"date":"2026-02-17","symbol":"IDYA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771318800000,"name":null,"time":"盘前","dateTimestamp":1771304400000,"actualEps":null},{"market":"US","date":"2025-11-04","symbol":"IDYA","fiscalQuarterEnding":"2025/09","expectedEps":0,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":1.33},{"market":"US","date":"2025-08-05","symbol":"IDYA","fiscalQuarterEnding":"2025/06","expectedEps":-0.85,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.88}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3125,"buy":0.625,"hold":0.0625,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":16,"updateTime":1764043200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IDYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IDYA","date":"2026-08-21","current":-20.566191,"percent":0.275244,"low":-34.624829,"twenty":-23.777689,"median":-17.608694,"eighty":-8.451147,"high":-4.624403,"avg":-16.951132,"sd":7.571995,"marketCap":3773703719},"quantilePoints":[{"date":"2021-08-27","current":-29.305801,"twenty":-16.592186,"median":-7.303089,"eighty":-3.542962,"marketCap":880023897},{"date":"2021-09-03","current":-31.722379,"twenty":-16.958969,"median":-7.318795,"eighty":-3.549073,"marketCap":952591312},{"date":"2021-09-10","current":-33.985523,"twenty":-17.480455,"median":-7.331359,"eighty":-3.549073,"marketCap":1020551273},{"date":"2021-09-17","current":-34.343535,"twenty":-18.002071,"median":-7.384758,"eighty":-3.550496,"marketCap":1031302001},{"date":"2021-09-24","current":-32.451188,"twenty":-18.564804,"median":-7.425593,"eighty":-3.554316,"marketCap":974476724},{"date":"2021-10-01","current":-32.655766,"twenty":-19.003246,"median":-7.482701,"eighty":-3.556676,"marketCap":980619997},{"date":"2021-10-08","current":-32.70691,"twenty":-19.603951,"median":-7.576366,"eighty":-3.556676,"marketCap":982155815},{"date":"2021-10-15","current":-29.57431,"twenty":-19.948284,"median":-7.607522,"eighty":-3.556676,"marketCap":888086943},{"date":"2021-10-22","current":-29.305801,"twenty":-20.299726,"median":-7.64547,"eighty":-3.561126,"marketCap":880023897},{"date":"2021-10-29","current":-27.413454,"twenty":-20.498333,"median":-7.666222,"eighty":-3.5648,"marketCap":823198619},{"date":"2021-11-05","current":-30.149685,"twenty":-20.989624,"median":-7.758551,"eighty":-3.569714,"marketCap":905364899},{"date":"2021-11-12","current":-29.446448,"twenty":-21.062795,"median":-7.793103,"eighty":-3.570043,"marketCap":884247397},{"date":"2021-11-19","current":-24.362497,"twenty":-21.240496,"median":-7.827655,"eighty":-3.571919,"marketCap":893738217},{"date":"2021-11-26","current":-24.981527,"twenty":-21.39159,"median":-7.890477,"eighty":-3.574612,"marketCap":916447328},{"date":"2021-12-03","current":-23.145422,"twenty":-21.857223,"median":-7.96045,"eighty":-3.584136,"marketCap":849089797},{"date":"2021-12-10","current":-22.914597,"twenty":-22.068374,"median":-8.022404,"eighty":-3.586999,"marketCap":840621993},{"date":"2021-12-17","current":-22.841153,"twenty":-22.307678,"median":-8.080851,"eighty":-3.590242,"marketCap":837927691},{"date":"2021-12-23","current":-24.519878,"twenty":-22.478131,"median":-8.112599,"eighty":-3.600896,"marketCap":899511720},{"date":"2021-12-31","current":-24.803163,"twenty":-22.661484,"median":-8.124771,"eighty":-3.607486,"marketCap":909904025},{"date":"2022-01-07","current":-18.854181,"twenty":-22.696715,"median":-8.133171,"eighty":-3.607884,"marketCap":691665623},{"date":"2022-01-14","current":-18.6968,"twenty":-22.661484,"median":-8.166895,"eighty":-3.6108,"marketCap":685892120},{"date":"2022-01-21","current":-16.01084,"twenty":-22.62885,"median":-8.217153,"eighty":-3.61443,"marketCap":587357674},{"date":"2022-01-28","current":-16.304617,"twenty":-22.589226,"median":-8.232117,"eighty":-3.61955,"marketCap":598134879},{"date":"2022-02-04","current":-16.336093,"twenty":-22.528306,"median":-8.279975,"eighty":-3.626979,"marketCap":599289580},{"date":"2022-02-11","current":-15.95838,"twenty":-22.480222,"median":-8.317669,"eighty":-3.641021,"marketCap":585433173},{"date":"2022-02-18","current":-14.290147,"twenty":-22.452959,"median":-8.349952,"eighty":-3.663377,"marketCap":524234045},{"date":"2022-02-25","current":-14.300639,"twenty":-22.416661,"median":-8.361644,"eighty":-3.680345,"marketCap":524618945},{"date":"2022-03-04","current":-12.663882,"twenty":-22.374982,"median":-8.467308,"eighty":-3.689682,"marketCap":464574517},{"date":"2022-03-11","current":-13.4298,"twenty":-22.27281,"median":-8.578381,"eighty":-3.700816,"marketCap":492672230},{"date":"2022-03-18","current":-9.803903,"twenty":-22.210534,"median":-8.63295,"eighty":-3.710538,"marketCap":487861813},{"date":"2022-03-25","current":-8.880178,"twenty":-22.137363,"median":-8.648165,"eighty":-3.728362,"marketCap":441895419},{"date":"2022-04-01","current":-8.849128,"twenty":-22.038758,"median":-8.676953,"eighty":-3.732947,"marketCap":440350330},{"date":"2022-04-08","current":-8.771505,"twenty":-22.005987,"median":-8.686118,"eighty":-3.735526,"marketCap":436487608},{"date":"2022-04-14","current":-8.39891,"twenty":-21.980806,"median":-8.678356,"eighty":-3.739591,"marketCap":417946542},{"date":"2022-04-22","current":-8.297999,"twenty":-21.967416,"median":-8.654251,"eighty":-3.742674,"marketCap":412925003},{"date":"2022-04-29","current":-7.445176,"twenty":-21.940847,"median":-8.644345,"eighty":-3.747479,"marketCap":370486844},{"date":"2022-05-06","current":-7.080292,"twenty":-21.836317,"median":-8.631683,"eighty":-3.752283,"marketCap":352329512},{"date":"2022-05-13","current":-7.388684,"twenty":-21.606351,"median":-8.578381,"eighty":-3.771501,"marketCap":404559983},{"date":"2022-05-20","current":-7.762705,"twenty":-21.554086,"median":-8.467308,"eighty":-3.779737,"marketCap":425039142},{"date":"2022-05-27","current":-7.621565,"twenty":-21.406546,"median":-8.392554,"eighty":-3.780239,"marketCap":417311157},{"date":"2022-06-03","current":-8.397835,"twenty":-21.39159,"median":-8.36786,"eighty":-3.788369,"marketCap":459815071},{"date":"2022-06-10","current":-8.037928,"twenty":-21.387041,"median":-8.380207,"eighty":-3.794466,"marketCap":440108711},{"date":"2022-06-17","current":-8.729514,"twenty":-21.336664,"median":-8.392554,"eighty":-3.799547,"marketCap":477975835},{"date":"2022-06-24","current":-9.795122,"twenty":-21.273946,"median":-8.39891,"eighty":-3.80666,"marketCap":536322117},{"date":"2022-07-01","current":-10.10563,"twenty":-21.225131,"median":-8.471248,"eighty":-3.810725,"marketCap":553323683},{"date":"2022-07-08","current":-10.888958,"twenty":-21.198073,"median":-8.557964,"eighty":-3.815416,"marketCap":596213996},{"date":"2022-07-15","current":-10.938357,"twenty":-21.154154,"median":-8.623821,"eighty":-3.823859,"marketCap":598918791},{"date":"2022-07-22","current":-10.50788,"twenty":-21.113328,"median":-8.640812,"eighty":-3.827243,"marketCap":575348438},{"date":"2022-07-29","current":-10.529051,"twenty":-21.08161,"median":-8.648165,"eighty":-3.852269,"marketCap":576507636},{"date":"2022-08-05","current":-11.107725,"twenty":-21.062795,"median":-8.674304,"eighty":-3.89073,"marketCap":608192372},{"date":"2022-08-12","current":-11.044212,"twenty":-21.057369,"median":-8.686118,"eighty":-3.902788,"marketCap":604714779},{"date":"2022-08-19","current":-6.087169,"twenty":-21.027635,"median":-8.674304,"eighty":-3.912344,"marketCap":400919180},{"date":"2022-08-26","current":-5.735068,"twenty":-20.992994,"median":-8.648165,"eighty":-3.917696,"marketCap":377728757},{"date":"2022-09-02","current":-5.597808,"twenty":-20.953825,"median":-8.640812,"eighty":-3.930533,"marketCap":368688422},{"date":"2022-09-09","current":-5.520226,"twenty":-20.872033,"median":-8.630797,"eighty":-3.94283,"marketCap":363578668},{"date":"2022-09-16","current":-7.849101,"twenty":-20.73156,"median":-8.578381,"eighty":-3.96417,"marketCap":516965327},{"date":"2022-09-23","current":-8.510226,"twenty":-20.611725,"median":-8.513329,"eighty":-3.972574,"marketCap":560509001},{"date":"2022-09-30","current":-10.493601,"twenty":-20.565232,"median":-8.578381,"eighty":-3.993719,"marketCap":691140025},{"date":"2022-10-07","current":-10.198204,"twenty":-20.477427,"median":-8.630797,"eighty":-4.008882,"marketCap":671684341},{"date":"2022-10-14","current":-10.950762,"twenty":-20.387531,"median":-8.642079,"eighty":-4.009677,"marketCap":721250013},{"date":"2022-10-21","current":-11.562654,"twenty":-20.357199,"median":-8.654251,"eighty":-4.014693,"marketCap":761551073},{"date":"2022-10-28","current":-11.956516,"twenty":-20.32892,"median":-8.675551,"eighty":-4.030286,"marketCap":787491986},{"date":"2022-11-04","current":-12.005748,"twenty":-20.283001,"median":-8.686118,"eighty":-4.065307,"marketCap":790734600},{"date":"2022-11-11","current":-15.768029,"twenty":-20.180562,"median":-8.713449,"eighty":-4.079563,"marketCap":830439027},{"date":"2022-11-18","current":-16.115182,"twenty":-20.035419,"median":-8.773737,"eighty":-4.104617,"marketCap":848722157},{"date":"2022-11-25","current":-16.060368,"twenty":-20.023491,"median":-8.779267,"eighty":-4.104763,"marketCap":845835347},{"date":"2022-12-02","current":-16.425792,"twenty":-19.948284,"median":-8.800314,"eighty":-4.104763,"marketCap":865080747},{"date":"2022-12-09","current":-15.384334,"twenty":-19.937676,"median":-8.842235,"eighty":-4.115583,"marketCap":810231356},{"date":"2022-12-16","current":-15.39347,"twenty":-19.766046,"median":-8.880178,"eighty":-4.122926,"marketCap":810712491},{"date":"2022-12-23","current":-15.548775,"twenty":-19.620281,"median":-8.920409,"eighty":-4.130826,"marketCap":818891787},{"date":"2022-12-30","current":-16.599368,"twenty":-19.607217,"median":-8.936255,"eighty":-4.130945,"marketCap":874222313},{"date":"2023-01-06","current":-15.777165,"twenty":-19.59823,"median":-8.94733,"eighty":-4.146129,"marketCap":830920162},{"date":"2023-01-13","current":-17.101825,"twenty":-19.554345,"median":-9.043188,"eighty":-4.162328,"marketCap":900684738},{"date":"2023-01-20","current":-16.106046,"twenty":-19.478065,"median":-9.066475,"eighty":-4.171098,"marketCap":848241022},{"date":"2023-01-27","current":-15.420877,"twenty":-19.243528,"median":-9.155743,"eighty":-4.18158,"marketCap":812155896},{"date":"2023-02-03","current":-16.042097,"twenty":-18.988351,"median":-9.163635,"eighty":-4.19168,"marketCap":844873077},{"date":"2023-02-10","current":-16.416656,"twenty":-18.921278,"median":-9.21308,"eighty":-4.201222,"marketCap":864599612},{"date":"2023-02-17","current":-16.16086,"twenty":-18.818457,"median":-9.237619,"eighty":-4.208561,"marketCap":851127832},{"date":"2023-02-24","current":-15.567046,"twenty":-18.755454,"median":-9.279961,"eighty":-4.218427,"marketCap":819854057},{"date":"2023-03-03","current":-15.7863,"twenty":-18.713587,"median":-9.288903,"eighty":-4.239786,"marketCap":831401297},{"date":"2023-03-10","current":-12.695923,"twenty":-18.685623,"median":-9.337354,"eighty":-4.268913,"marketCap":744679346},{"date":"2023-03-17","current":-12.365944,"twenty":-18.625694,"median":-9.47488,"eighty":-4.277714,"marketCap":725324457},{"date":"2023-03-24","current":-11.450254,"twenty":-18.520909,"median":-9.51831,"eighty":-4.30099,"marketCap":671614641},{"date":"2023-03-31","current":-11.326512,"twenty":-18.333889,"median":-9.637448,"eighty":-4.31253,"marketCap":664356558},{"date":"2023-04-06","current":-11.343011,"twenty":-18.288121,"median":-9.673933,"eighty":-4.318821,"marketCap":665324302},{"date":"2023-04-14","current":-11.433755,"twenty":-18.224659,"median":-9.699267,"eighty":-4.318821,"marketCap":670646896},{"date":"2023-04-21","current":-12.012005,"twenty":-18.140723,"median":-9.745723,"eighty":-4.318821,"marketCap":704564136},{"date":"2023-04-28","current":-17.665967,"twenty":-18.140723,"median":-9.757173,"eighty":-4.324014,"marketCap":1036197283},{"date":"2023-05-05","current":-18.5444,"twenty":-18.345331,"median":-9.795122,"eighty":-4.333623,"marketCap":1087721785},{"date":"2023-05-12","current":-17.975574,"twenty":-18.548481,"median":-9.809491,"eighty":-4.342105,"marketCap":1227408161},{"date":"2023-05-19","current":-17.7789,"twenty":-18.385145,"median":-9.923908,"eighty":-4.345574,"marketCap":1213978850},{"date":"2023-05-26","current":-18.14807,"twenty":-18.548481,"median":-10.050322,"eighty":-4.359142,"marketCap":1239186528},{"date":"2023-06-02","current":-20.069433,"twenty":-18.624,"median":-10.097881,"eighty":-4.366759,"marketCap":1370381033},{"date":"2023-06-09","current":-21.42026,"twenty":-18.679679,"median":-10.133562,"eighty":-4.369631,"marketCap":1462618218},{"date":"2023-06-16","current":-20.925237,"twenty":-18.866911,"median":-10.16981,"eighty":-4.375728,"marketCap":1428817014},{"date":"2023-06-23","current":-21.134993,"twenty":-18.937913,"median":-10.21543,"eighty":-4.380543,"marketCap":1443139558},{"date":"2023-06-30","current":-19.937075,"twenty":-19.13128,"median":-10.25893,"eighty":-4.382308,"marketCap":1361343322},{"date":"2023-07-07","current":-19.327719,"twenty":-19.403716,"median":-10.300042,"eighty":-4.384874,"marketCap":1319735326},{"date":"2023-07-14","current":-19.516534,"twenty":-19.527631,"median":-10.366739,"eighty":-4.396081,"marketCap":1332627944},{"date":"2023-07-21","current":-18.778441,"twenty":-19.516534,"median":-10.433806,"eighty":-4.40569,"marketCap":1282229526},{"date":"2023-07-28","current":-18.083261,"twenty":-19.456456,"median":-10.472595,"eighty":-4.425522,"marketCap":1234761248},{"date":"2023-08-04","current":-18.684034,"twenty":-19.430709,"median":-10.508916,"eighty":-4.445846,"marketCap":1275783217},{"date":"2023-08-11","current":-19.793943,"twenty":-19.456456,"median":-10.529051,"eighty":-4.466169,"marketCap":1467760467},{"date":"2023-08-18","current":-19.297154,"twenty":-19.516534,"median":-10.56417,"eighty":-4.47125,"marketCap":1430922557},{"date":"2023-08-25","current":-21.788862,"twenty":-19.594416,"median":-10.725698,"eighty":-4.489816,"marketCap":1615687698},{"date":"2023-09-01","current":-22.790203,"twenty":-19.620281,"median":-10.783103,"eighty":-4.508424,"marketCap":1689939110},{"date":"2023-09-08","current":-21.773337,"twenty":-19.662379,"median":-10.81952,"eighty":-4.516812,"marketCap":1614536513},{"date":"2023-09-15","current":-22.891113,"twenty":-19.937195,"median":-10.874844,"eighty":-4.541754,"marketCap":1697421810},{"date":"2023-09-22","current":-21.88201,"twenty":-20.044607,"median":-10.927771,"eighty":-4.55153,"marketCap":1622594806},{"date":"2023-09-29","current":-20.640037,"twenty":-20.232827,"median":-10.973642,"eighty":-4.576935,"marketCap":1530500032},{"date":"2023-10-06","current":-20.546889,"twenty":-20.307025,"median":-10.998264,"eighty":-4.587214,"marketCap":1523592923},{"date":"2023-10-13","current":-21.191163,"twenty":-20.399581,"median":-11.044212,"eighty":-4.596272,"marketCap":1571367088},{"date":"2023-10-20","current":-20.127723,"twenty":-20.430908,"median":-11.063294,"eighty":-4.598275,"marketCap":1492510937},{"date":"2023-10-27","current":-22.829497,"twenty":-20.455558,"median":-11.08551,"eighty":-4.599291,"marketCap":1692852872},{"date":"2023-11-03","current":-25.350703,"twenty":-20.512907,"median":-11.133626,"eighty":-4.606404,"marketCap":1879805335},{"date":"2023-11-10","current":-18.349717,"twenty":-20.534125,"median":-11.159417,"eighty":-4.623679,"marketCap":1893819287},{"date":"2023-11-17","current":-18.699474,"twenty":-20.512907,"median":-11.219301,"eighty":-4.647268,"marketCap":1929916591},{"date":"2023-11-24","current":-19.986078,"twenty":-20.508077,"median":-11.235768,"eighty":-4.660326,"marketCap":2062703104},{"date":"2023-12-01","current":-19.642567,"twenty":-20.498333,"median":-11.326512,"eighty":-4.691605,"marketCap":2027250394},{"date":"2023-12-08","current":-19.523899,"twenty":-20.469266,"median":-11.343011,"eighty":-4.703566,"marketCap":2015003094},{"date":"2023-12-15","current":-21.372612,"twenty":-20.485729,"median":-11.403123,"eighty":-4.710056,"marketCap":2205803131},{"date":"2023-12-22","current":-21.178997,"twenty":-20.539127,"median":-11.433755,"eighty":-4.725299,"marketCap":2185820695},{"date":"2023-12-29","current":-22.378161,"twenty":-20.560916,"median":-11.460738,"eighty":-4.752445,"marketCap":2309582881},{"date":"2024-01-05","current":-21.616192,"twenty":-20.635863,"median":-11.478255,"eighty":-4.774704,"marketCap":2230942325},{"date":"2024-01-12","current":-24.694637,"twenty":-20.763319,"median":-11.573996,"eighty":-4.807425,"marketCap":2548659433},{"date":"2024-01-19","current":-28.378521,"twenty":-20.874895,"median":-11.672989,"eighty":-4.871722,"marketCap":2928862002},{"date":"2024-01-26","current":-30.347082,"twenty":-20.925237,"median":-11.754932,"eighty":-4.928537,"marketCap":3132031295},{"date":"2024-02-02","current":-31.796601,"twenty":-20.995241,"median":-11.84903,"eighty":-5.022175,"marketCap":3281631848},{"date":"2024-02-09","current":-31.989395,"twenty":-21.094154,"median":-11.907283,"eighty":-5.032659,"marketCap":3301529459},{"date":"2024-02-16","current":-33.160435,"twenty":-21.134993,"median":-12.008876,"eighty":-5.086047,"marketCap":3422389019},{"date":"2024-02-23","current":-29.405371,"twenty":-21.18143,"median":-12.106086,"eighty":-5.094177,"marketCap":3321660162},{"date":"2024-03-01","current":-29.504379,"twenty":-21.252364,"median":-12.196466,"eighty":-5.100274,"marketCap":3332844203},{"date":"2024-03-08","current":-29.854208,"twenty":-21.362618,"median":-12.275201,"eighty":-5.134457,"marketCap":3372361147},{"date":"2024-03-15","current":-29.570385,"twenty":-21.39159,"median":-12.312278,"eighty":-5.167912,"marketCap":3340300230},{"date":"2024-03-22","current":-30.118229,"twenty":-21.456111,"median":-12.35282,"eighty":-5.193104,"marketCap":3402185256},{"date":"2024-03-28","current":-28.586905,"twenty":-21.586005,"median":-12.411316,"eighty":-5.211962,"marketCap":3229205423},{"date":"2024-04-05","current":-27.326204,"twenty":-21.698819,"median":-12.663882,"eighty":-5.224529,"marketCap":3086795302},{"date":"2024-04-12","current":-28.685913,"twenty":-21.801282,"median":-12.695915,"eighty":-5.23565,"marketCap":3240389464},{"date":"2024-04-19","current":-24.831203,"twenty":-21.90599,"median":-12.746573,"eighty":-5.260951,"marketCap":2804957470},{"date":"2024-04-26","current":-25.561122,"twenty":-21.970513,"median":-12.778856,"eighty":-5.33492,"marketCap":2887409933},{"date":"2024-05-03","current":-27.460667,"twenty":-22.002271,"median":-12.852662,"eighty":-5.443511,"marketCap":3101984415},{"date":"2024-05-10","current":-23.864016,"twenty":-22.106629,"median":-13.01501,"eighty":-5.504053,"marketCap":3075904561},{"date":"2024-05-17","current":-24.386628,"twenty":-22.316456,"median":-13.122963,"eighty":-5.514677,"marketCap":3143265660},{"date":"2024-05-24","current":-22.578036,"twenty":-22.408348,"median":-13.19089,"eighty":-5.517064,"marketCap":2910150846},{"date":"2024-05-31","current":-21.016071,"twenty":-22.408348,"median":-13.405255,"eighty":-5.517064,"marketCap":2708824416},{"date":"2024-06-07","current":-23.270938,"twenty":-22.480222,"median":-13.492753,"eighty":-5.517064,"marketCap":2999461067},{"date":"2024-06-14","current":-22.859895,"twenty":-22.573944,"median":-13.658594,"eighty":-5.526194,"marketCap":2946480428},{"date":"2024-06-21","current":-21.297929,"twenty":-22.578036,"median":-13.849482,"eighty":-5.550065,"marketCap":2745153997},{"date":"2024-06-28","current":-20.18224,"twenty":-22.604654,"median":-14.065248,"eighty":-5.737455,"marketCap":2601349404},{"date":"2024-07-05","current":-19.548058,"twenty":-22.604654,"median":-14.207014,"eighty":-5.875249,"marketCap":2519607846},{"date":"2024-07-12","current":-25.833502,"twenty":-22.663386,"median":-14.56294,"eighty":-6.158782,"marketCap":3329757590},{"date":"2024-07-15","current":-26.081274,"twenty":-22.683944,"median":-14.611833,"eighty":-6.204137,"marketCap":3361693680},{"date":"2024-08-02","current":-27.685273,"twenty":-22.729538,"median":-15.101131,"eighty":-7.080248,"marketCap":3568437841},{"date":"2024-08-09","current":-20.650678,"twenty":-22.791755,"median":-15.174216,"eighty":-7.173892,"marketCap":3174814544},{"date":"2024-08-16","current":-20.941919,"twenty":-22.791755,"median":-15.356928,"eighty":-7.243187,"marketCap":3219589736},{"date":"2024-08-23","current":-21.062812,"twenty":-22.791755,"median":-15.420877,"eighty":-7.280035,"marketCap":3238175665},{"date":"2024-08-30","current":-21.524403,"twenty":-22.791755,"median":-15.493961,"eighty":-7.318659,"marketCap":3309140119},{"date":"2024-09-06","current":-20.53528,"twenty":-22.791755,"median":-15.548775,"eighty":-7.330832,"marketCap":3157073430},{"date":"2024-09-13","current":-19.842894,"twenty":-22.791755,"median":-15.658402,"eighty":-7.386643,"marketCap":3050626748},{"date":"2024-09-20","current":-19.386799,"twenty":-22.791755,"median":-15.731487,"eighty":-7.41883,"marketCap":2980507108},{"date":"2024-09-27","current":-16.76013,"twenty":-22.791755,"median":-15.7863,"eighty":-7.470507,"marketCap":2576685567},{"date":"2024-10-04","current":-16.073239,"twenty":-22.791755,"median":-15.877656,"eighty":-7.496684,"marketCap":2471083699},{"date":"2024-10-11","current":-16.595276,"twenty":-22.791755,"median":-15.923334,"eighty":-7.600254,"marketCap":2551341118},{"date":"2024-10-18","current":-16.864537,"twenty":-22.791755,"median":-15.959877,"eighty":-7.641123,"marketCap":2592737050},{"date":"2024-10-25","current":-16.045763,"twenty":-22.791755,"median":-16.042097,"eighty":-7.711567,"marketCap":2466859624},{"date":"2024-10-31","current":-16.188637,"twenty":-22.791755,"median":-16.087775,"eighty":-7.784511,"marketCap":2488824813},{"date":"2024-11-08","current":-14.552491,"twenty":-22.793308,"median":-16.087775,"eighty":-7.860776,"marketCap":2592089652},{"date":"2024-11-15","current":-14.300163,"twenty":-22.793308,"median":-16.087775,"eighty":-7.961667,"marketCap":2547145116},{"date":"2024-11-22","current":-12.907511,"twenty":-22.793308,"median":-16.087775,"eighty":-8.046396,"marketCap":2299085853},{"date":"2024-11-29","current":-13.276297,"twenty":-22.793308,"median":-16.087775,"eighty":-8.103024,"marketCap":2364774020},{"date":"2024-12-06","current":-12.795905,"twenty":-22.793308,"median":-16.087775,"eighty":-8.12743,"marketCap":2279206539},{"date":"2024-12-13","current":-12.50961,"twenty":-22.793308,"median":-16.087775,"eighty":-8.178203,"marketCap":2228211778},{"date":"2024-12-20","current":-12.029218,"twenty":-22.793308,"median":-16.087775,"eighty":-8.232893,"marketCap":2142644297},{"date":"2024-12-27","current":-12.54843,"twenty":-22.793308,"median":-16.087775,"eighty":-8.272654,"marketCap":2235126322},{"date":"2025-01-03","current":-12.208758,"twenty":-22.793308,"median":-16.087775,"eighty":-8.306032,"marketCap":2174624062},{"date":"2025-01-10","current":-12.058333,"twenty":-22.79486,"median":-16.087775,"eighty":-8.349042,"marketCap":2147830205},{"date":"2025-01-17","current":-11.024761,"twenty":-22.79486,"median":-16.087775,"eighty":-8.387198,"marketCap":1963730473},{"date":"2025-01-24","current":-11.301351,"twenty":-22.79486,"median":-16.087775,"eighty":-8.421336,"marketCap":2012996598},{"date":"2025-01-31","current":-11.587645,"twenty":-22.79486,"median":-16.087775,"eighty":-8.512709,"marketCap":2063991360},{"date":"2025-02-07","current":-11.626465,"twenty":-22.79486,"median":-16.087775,"eighty":-8.629402,"marketCap":2070905904},{"date":"2025-02-14","current":-6.537248,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1794324147},{"date":"2025-02-21","current":-6.930226,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1902187506},{"date":"2025-02-28","current":-6.455028,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1771756793},{"date":"2025-03-07","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-03-14","current":-6.046805,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1659708933},{"date":"2025-03-21","current":-5.880964,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1614189490},{"date":"2025-03-28","current":-5.558851,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1525776725},{"date":"2025-04-04","current":-4.965652,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1362957177},{"date":"2025-04-11","current":-5.029437,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1380464656},{"date":"2025-04-17","current":-5.160196,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1416354986},{"date":"2025-04-25","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-05-02","current":-6.528381,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1791890393},{"date":"2025-05-09","current":-5.185048,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1592240087},{"date":"2025-05-16","current":-4.936919,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1516043779},{"date":"2025-05-23","current":-5.327651,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1636031068},{"date":"2025-05-30","current":-5.718383,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1756018358},{"date":"2025-06-06","current":-6.01785,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1847979419},{"date":"2025-06-13","current":-6.354393,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1951326135},{"date":"2025-06-20","current":-6.234607,"twenty":-22.797965,"median":-16.087775,"eighty":-8.644345,"marketCap":1914541711},{"date":"2025-06-27","current":-6.357245,"twenty":-22.797965,"median":-16.087775,"eighty":-8.623821,"marketCap":1952201955},{"date":"2025-07-03","current":-6.303056,"twenty":-22.797965,"median":-16.087775,"eighty":-8.578381,"marketCap":1935561382},{"date":"2025-07-11","current":-6.5027,"twenty":-22.797965,"median":-16.087775,"eighty":-8.537547,"marketCap":1996868756},{"date":"2025-07-18","current":-6.300204,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":1934685562},{"date":"2025-07-25","current":-7.081669,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2174660141},{"date":"2025-08-01","current":-6.94477,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2132620799},{"date":"2025-08-08","current":-5.919479,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":1964095003},{"date":"2025-08-15","current":-6.437202,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2135876627},{"date":"2025-08-22","current":-6.50588,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2158663986},{"date":"2025-08-29","current":-6.585123,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2184957091},{"date":"2025-09-05","current":-6.822853,"twenty":-22.800061,"median":-16.094245,"eighty":-8.503193,"marketCap":2263836409},{"date":"2025-09-12","current":-6.585123,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2184957091},{"date":"2025-09-19","current":-6.92587,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2298017446},{"date":"2025-09-26","current":-6.785873,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2251566293},{"date":"2025-10-03","current":-7.184731,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2383908259},{"date":"2025-10-10","current":-7.076432,"twenty":-22.797965,"median":-16.087775,"eighty":-8.426063,"marketCap":2347974347},{"date":"2025-10-17","current":-7.314162,"twenty":-22.797965,"median":-16.087775,"eighty":-8.383627,"marketCap":2426853665},{"date":"2025-10-24","current":-7.506988,"twenty":-22.797965,"median":-16.087775,"eighty":-8.36786,"marketCap":2490833556},{"date":"2025-10-31","current":-8.346967,"twenty":-22.797965,"median":-16.087775,"eighty":-8.39891,"marketCap":2769540477},{"date":"2025-11-07","current":-16.280273,"twenty":-22.797965,"median":-16.115182,"eighty":-8.446927,"marketCap":2616842278},{"date":"2025-11-14","current":-17.354717,"twenty":-22.797965,"median":-16.176647,"eighty":-8.45396,"marketCap":2789545102},{"date":"2025-11-21","current":-18.085556,"twenty":-22.797965,"median":-16.210617,"eighty":-8.45396,"marketCap":2907018089},{"date":"2025-11-28","current":-19.427247,"twenty":-22.797965,"median":-16.280273,"eighty":-8.45396,"marketCap":3122677452},{"date":"2025-12-05","current":-19.639954,"twenty":-22.797965,"median":-16.315109,"eighty":-8.45396,"marketCap":3156867352},{"date":"2025-12-12","current":-18.303718,"twenty":-22.797965,"median":-16.365703,"eighty":-8.45396,"marketCap":2942084652},{"date":"2025-12-19","current":-18.140097,"twenty":-22.797965,"median":-16.416656,"eighty":-8.45396,"marketCap":2915784730},{"date":"2025-12-26","current":-19.459971,"twenty":-22.797965,"median":-16.47147,"eighty":-8.45396,"marketCap":3127937437},{"date":"2026-01-02","current":-18.854574,"twenty":-22.797965,"median":-16.52495,"eighty":-8.45396,"marketCap":3030627724},{"date":"2026-01-09","current":-19.869024,"twenty":-22.797965,"median":-16.599368,"eighty":-8.45396,"marketCap":3193687243},{"date":"2026-01-16","current":-19.667225,"twenty":-22.797965,"median":-16.654182,"eighty":-8.45396,"marketCap":3161250672},{"date":"2026-01-23","current":-19.743581,"twenty":-22.797965,"median":-16.776759,"eighty":-8.45396,"marketCap":3173523969},{"date":"2026-01-30","current":-17.992838,"twenty":-22.797965,"median":-16.864537,"eighty":-8.45396,"marketCap":2892114799},{"date":"2026-02-06","current":-17.327447,"twenty":-22.797965,"median":-16.944631,"eighty":-8.45396,"marketCap":2785161782},{"date":"2026-02-13","current":-17.191096,"twenty":-22.797965,"median":-16.997091,"eighty":-8.45396,"marketCap":2763245180},{"date":"2026-02-20","current":-25.410135,"twenty":-22.829497,"median":-17.067857,"eighty":-8.45396,"marketCap":2889081488},{"date":"2026-02-27","current":-24.63779,"twenty":-22.859895,"median":-17.238205,"eighty":-8.45396,"marketCap":2801267461},{"date":"2026-03-06","current":-25.510539,"twenty":-22.975694,"median":-17.398349,"eighty":-8.45396,"marketCap":2900497311},{"date":"2026-03-13","current":-25.356071,"twenty":-23.059318,"median":-17.427264,"eighty":-8.45396,"marketCap":2882934506},{"date":"2026-03-20","current":-25.178431,"twenty":-23.145422,"median":-17.532711,"eighty":-8.45396,"marketCap":2862737280},{"date":"2026-03-27","current":-24.784536,"twenty":-23.270938,"median":-17.545608,"eighty":-8.45396,"marketCap":2817952126},{"date":"2026-04-02","current":-25.08575,"twenty":-23.407723,"median":-17.545608,"eighty":-8.45396,"marketCap":2852199596},{"date":"2026-04-10","current":-23.94268,"twenty":-23.579678,"median":-17.545608,"eighty":-8.45396,"marketCap":2722234837},{"date":"2026-04-17","current":-25.10892,"twenty":-23.717857,"median":-17.696952,"eighty":-8.45396,"marketCap":2854834017},{"date":"2026-04-24","current":-23.710977,"twenty":-23.781807,"median":-17.753729,"eighty":-8.45396,"marketCap":2695890628},{"date":"2026-05-01","current":-22.475225,"twenty":-23.781807,"median":-17.753729,"eighty":-8.45396,"marketCap":2555388185},{"date":"2026-05-08","current":-17.715337,"twenty":-23.781807,"median":-17.742113,"eighty":-8.45396,"marketCap":2481192380},{"date":"2026-05-15","current":-18.091725,"twenty":-23.781807,"median":-17.665967,"eighty":-8.45396,"marketCap":2533908932},{"date":"2026-05-22","current":-18.530845,"twenty":-23.781807,"median":-17.665967,"eighty":-8.45396,"marketCap":2595411576},{"date":"2026-05-29","current":-18.405382,"twenty":-23.784228,"median":-17.665782,"eighty":-8.452553,"marketCap":2577839392},{"date":"2026-06-05","current":-18.330104,"twenty":-23.781807,"median":-17.665596,"eighty":-8.45396,"marketCap":2567296082},{"date":"2026-06-12","current":-18.091725,"twenty":-23.781807,"median":-17.640059,"eighty":-8.45396,"marketCap":2533908932},{"date":"2026-06-18","current":-19.609824,"twenty":-23.781807,"median":-17.640059,"eighty":-8.45396,"marketCap":2746532359},{"date":"2026-06-26","current":-22.765212,"twenty":-23.784228,"median":-17.624377,"eighty":-8.452553,"marketCap":3188472786},{"date":"2026-07-02","current":-24.555061,"twenty":-23.887071,"median":-17.624377,"eighty":-8.452553,"marketCap":3439157354},{"date":"2026-07-10","current":-25.308617,"twenty":-24.08363,"median":-17.624377,"eighty":-8.452553,"marketCap":3544699645},{"date":"2026-07-17","current":-24.39213,"twenty":-24.253162,"median":-17.624377,"eighty":-8.452553,"marketCap":3416337399},{"date":"2026-07-24","current":-24.595794,"twenty":-24.196085,"median":-17.624377,"eighty":-8.452553,"marketCap":3444862343},{"date":"2026-07-31","current":-24.711204,"twenty":-24.166881,"median":-17.608694,"eighty":-8.451147,"marketCap":3461026478},{"date":"2026-08-07","current":-19.97931,"twenty":-24.08533,"median":-17.608694,"eighty":-8.451147,"marketCap":3496778900},{"date":"2026-08-14","current":-20.221885,"twenty":-23.924144,"median":-17.608694,"eighty":-8.451147,"marketCap":3539234273},{"date":"2026-08-21","current":-21.561557,"twenty":-23.777689,"median":-17.608694,"eighty":-8.451147,"marketCap":3773703719}],"updateTime":1787596159018},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDYA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197034181","title":"IDEAYA Biosciences：计划于2026年下半年启动与罗氏RG6505联合治疗的1期临床队列，针对MTAP缺失及RAS突变型胰腺导管腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1197034181","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197034181?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 18:03","pubTimestamp":1787133786,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences宣布，其计划在2026年下半年启动一项1期联合治疗队列研究。该研究将评估IDEAYA在研药物与罗氏旗下RG6505的组合疗法，目标适应症为MTAP基因缺失且携带RAS突变的胰腺导管腺癌。这一临床布局标志着IDEAYA在肿瘤精准医疗领域的又一关键推进。IDEAYA方面暂未披露更多关于该队列的具体剂量方案或患者招募细节，但此次与罗氏的合作无疑将为双方在肿瘤免疫联合疗法领域积累宝贵的数据与经验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159671526","title":"IDEAYA Biosciences宣布与Genentech达成临床合作，聚焦MTAP缺失型KRAS G12d突变胰腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1159671526","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159671526?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 18:01","pubTimestamp":1787133683,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences今日宣布，已与Genentech达成一项临床合作，双方将携手推进针对MTAP缺失型KRAS G12d突变胰腺癌的联合研究。这一合作聚焦于特定基因组背景下的胰腺癌患者群体——即同时存在MTAP基因缺失与KRAS G12d突变的病例。IDEAYA Biosciences表示，此次与Genentech的联手，旨在探索新型联合治疗策略，以应对这一难治性癌症亚型中未被满足的临床需求。IDEAYA Biosciences与Genentech此次的临床协作，或将推动这一细分领域的治疗格局发生转变。市场对此消息反应积极，IDEAYA Biosciences股价在公告后出现波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169026792","title":"IDEAYA Biosciences宣布IDE892——有望成为同类最佳MTA协同PRMT5抑制剂——启动MTAP缺失胰腺癌和肺癌1/2期研究第二部分单药扩展阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1169026792","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169026792?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 18:01","pubTimestamp":1785146471,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences今日正式宣布，其候选药物IDE892——一种被视作具有“同类最佳”潜力的MTA协同PRMT5抑制剂——已启动1/2期临床研究的第二部分单药扩展阶段。该研究聚焦于MTAP基因缺失的胰腺癌和肺癌患者。此次启动的单药扩展部分，将在一系列经过严格筛选的MTAP缺失肿瘤患者中，进一步评估IDE892的安全性、耐受性及初步抗肿瘤活性。IDEAYA公司表示，基于前期临床数据，IDE892展现出令人鼓舞的潜力，有望改变当前MTAP缺失癌症的治疗格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642985654","title":"市场快讯——美股行情动态-托尔兄弟、TG Therapeutics、CECO Environmental","url":"https://stock-news.laohu8.com/highlight/detail?id=2642985654","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642985654?lang=zh_cn&edition=fundamental","pubTime":"2026-06-09 21:08","pubTimestamp":1781010533,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nL4S42H10C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CECO","LU1670756490.USD","LU0225283273.USD","IDYA","NUVL","TGTX","SIRI","LU0971552673.USD","SG9999001176.USD","LU0203347892.USD","BK4007","BK4559","SJM","BK4585","BK4588","LU1400636491.USD","TOL","LU0225771236.USD","ACOG","GSK.UK","BK4596","LU1983299246.USD","LU0545562505.USD","LU0306807586.USD","LU0557290698.USD","SG9999001176.SGD","CRVS","RDW","LU1046248800.SGD","RNAC","LU0161305163.EUR","LU1228905037.USD","LU0971552830.HKD","IE0031619046.USD","BK5011","ARCB","LEN","BK4161","IE00BQJZX424.USD","LU1645745479.HKD","IE00BFMHRM44.USD","LU1302929846.USD","RDWU","BK4212","LU0109981661.USD","LU1015430645.USD","PRGO","BK4100","SG9999013999.USD","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642467630","title":"市场快讯——美股行情-Nuvalent、Sirius XM、J.M. Smucker","url":"https://stock-news.laohu8.com/highlight/detail?id=2642467630","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642467630?lang=zh_cn&edition=fundamental","pubTime":"2026-06-09 20:07","pubTimestamp":1781006873,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nL4S42H0WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","IDYA","LU1015430645.USD","BK4139","BK4212","LU1670756490.USD","LU1228905540.USD","BK4585","LU0306807586.USD","LU1064927863.SGD","LU0109981661.USD","BK5011","LU1645745479.HKD","LU1481600234.SGD","LU2646069778.SGD","IE00B3T34201.USD","LU0575583348.USD","SGXZ57979304.SGD","RNAC","LU1302929846.USD","LU0985481810.HKD","LU0225283273.USD","ARCB","LU0545562505.USD","IE00BQJZX424.USD","LU0557290698.USD","LU1487256676.USD","SJM","LU0211331839.USD","IE00BWDBJ516.SGD","LU1983299246.USD","SIRI","SG9999013999.USD","BK4588","LU1309081286.SGD","LU1046248800.SGD","LU2468319806.SGD","LU2089984988.USD","IE0034235071.USD","LU1202635105.USD","LU0289739699.SGD","LU0203347892.USD","LU0225771236.USD","LU1098665638.USD","SG9999001176.SGD","LU0321505868.SGD","BK4100","LU1400636657.SGD","NUVL","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642342354","title":"热门话题-IDEAYA生物科技因计划出售3亿美元股票而股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2642342354","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642342354?lang=zh_cn&edition=fundamental","pubTime":"2026-06-09 05:08","pubTimestamp":1780952927,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nL4S42G1QU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","IE00BN8TJ469.HKD","LU1720051108.HKD","LU1974910355.USD","LU0310799852.SGD","LU0208291251.USD","LU2505996509.AUD","LU1267930490.SGD","LU2357305700.SGD","IE00BJT1NW94.SGD","IE00BJLML261.HKD","IE00BJTD4N35.SGD","LU1084165304.USD","BK4504","IE00BJTD4V19.USD","BK4534","LU1244550494.USD","IE00B1BXHZ80.USD","LU2430703178.SGD","IDYA","LU2264538146.SGD","LU2381873111.SGD","LU0170899867.USD","BK4533","IE00B775SV38.USD","LU2756315318.SGD","LU2237443465.HKD","LU0345770308.USD","LU0640476718.USD","IE00BWXC8680.SGD","IE0009355771.USD","JPMO","TNGX","LU0211331839.USD","LU2023250330.USD","IE00BKDWB100.SGD","LU1116320737.USD","LU1064131342.USD","LU0187121727.USD","LU0496365809.HKD","JPX","LU0417517546.SGD","JPO","IE00B3S45H60.SGD","IE00BBT3K403.USD","BK4516","IE00BDCRKT87.USD","LU0203347892.USD","LU0820561818.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193372500","title":"IDEAYA Biosciences 宣布拟进行高达3亿美元的普通股及预融资权证公开发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1193372500","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193372500?lang=zh_cn&edition=fundamental","pubTime":"2026-06-09 04:02","pubTimestamp":1780948937,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences 宣布，公司计划进行一项公开发行，预计募集资金总额最高可达3亿美元。此次发行将包含公司普通股以及与之配套的预融资权证。\n此举旨在为公司后续的研发活动及一般运营提供资金支持。具体的发行条款，包括发行的股票数量、权证条款及最终定价，将根据市场状况及其他因素最终确定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102086458","title":"IDEAYA Biosciences宣布与罗氏在MTAP缺失型RAS突变胰腺癌领域达成临床合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1102086458","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102086458?lang=zh_cn&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480823,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences宣布，已与罗氏就针对MTAP缺失型RAS突变胰腺癌的联合疗法开发达成临床合作。此项合作旨在探索IDEAYA的靶向疗法与罗氏的相关疗法相结合，为这一难治性癌症亚型患者开发新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146226364","title":"IDEAYA与施维雅在ASCO公布Darovasertib联合疗法一线治疗HLA-A2:01阴性转移性葡萄膜黑色素瘤的2/3期关键试验完整数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1146226364","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146226364?lang=zh_cn&edition=fundamental","pubTime":"2026-06-01 23:00","pubTimestamp":1780326016,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences与合作伙伴施维雅于美国临床肿瘤学会年会的一场最新突破性口头报告中，公布了其关键性2/3期OPTIMUM-02试验的完整数据。该试验评估了Darovasertib联合疗法，作为一线治疗方案，用于HLA-A2:01阴性转移性葡萄膜黑色素瘤患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103177449","title":"IDEAYA Biosciences公布截至2026年3月31日持有约9.73亿美元现金及证券 资金可支撑运营至2030年","url":"https://stock-news.laohu8.com/highlight/detail?id=1103177449","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103177449?lang=zh_cn&edition=fundamental","pubTime":"2026-05-05 18:17","pubTimestamp":1777976237,"startTime":"0","endTime":"0","summary":"生物科技公司IDEAYA Biosciences（股票代码：IDYA）最新财务数据显示，截至2026年3月31日，公司持有的现金及证券总额约为9.73亿美元。这一资金规模足以支持公司运营至2030年，资金续航时间与先前预期保持一致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168624894","title":"IDEAYA Biosciences将于五月启动RTOR申请，新药上市申请预计2026年下半年完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1168624894","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168624894?lang=zh_cn&edition=fundamental","pubTime":"2026-04-30 18:11","pubTimestamp":1777543916,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences宣布，公司计划于今年五月启动实时肿瘤学审评（RTOR）提交程序。这一重要举措标志着其候选药物开发进入关键阶段。\n根据最新时间表，IDEAYA Biosciences预计将在2026年下半年完成新药上市申请（NDA）的提交工作。该时间节点的确立为后续商业化进程奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627413276","title":"美国研究综述-百健、Equinix、Revolution Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2627413276","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627413276?lang=zh_cn&edition=fundamental","pubTime":"2026-04-14 15:46","pubTimestamp":1776152774,"startTime":"0","endTime":"0","summary":"美国研究综述-百健、Equinix、Revolution Medicines路透4月14日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括百健、Equinix 和 Revolution Medicines。要闻 * 百健BIIB.O：Piper Sandler将其评级从中性上调至增持 * Equinix Inc EQIX.O：杰富瑞将目标价从1,000美元上调至1,220美元 * Revolution Medicines Inc RVMD.O：Raymond James将目标价从135美元上调至175美元 * SBA Communications Corp SBAC.O：杰富瑞将目标价从182美元上调至213美元 * Williams Companies Inc WMB.N：Raymond James将目标价从73美元上调至78美元以下是路透周二报道的美国公司研究报告摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL4S40X0LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MKC","BIIB","BDX","EQIX","BSX","HSY","DLR","AVB","BRBR","NTRA","MSFU","ADPT","SJM","GIS","BEG","CUBE","ASAN","KHC","EXR","HUBS","GH","BEZ","CAG","IDYA","NEO","MSFW","BL","WGS","CBRE","CPT","MSFT","BE","MAA","ADGM","PODD","MSFX","CAI","MRNX","MRNA","INSP","MSFO","MSFD","JAN","MRNY","CPB","LNG","NSA","TREE","BEX","FLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627279413","title":"美国研究综述-百健、Equinix、Revolution Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2627279413","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627279413?lang=zh_cn&edition=fundamental","pubTime":"2026-04-14 15:46","pubTimestamp":1776152774,"startTime":"0","endTime":"0","summary":"美国研究综述-百健、Equinix、Revolution Medicines路透4月14日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括百健、Equinix 和 Revolution Medicines。要闻 * 百健BIIB.O：Piper Sandler将其评级从中性上调至增持 * Equinix Inc EQIX.O：杰富瑞将目标价从1,000美元上调至1,220美元 * Revolution Medicines Inc RVMD.O：Raymond James将目标价从135美元上调至175美元 * SBA Communications Corp SBAC.O：杰富瑞将目标价从182美元上调至213美元 * Williams Companies Inc WMB.N：Raymond James将目标价从73美元上调至78美元以下是路透周二报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL4T40X0LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BL","FLS","MSFL","ADPT","BDX","CUBE","AVB","LNG","MSFD","JAN","IDYA","NSA","HUBS","WGS","ADGM","MAA","TREE","EQIX","CPT","NEO","BIIB","MSFT","MSFX","DLR","BEX","ASAN","CPB","EXR","NTRA","BEZ","KHC","MSFW","BRBR","GH","MRNX","HSY","CBRE","PODD","CAI","MKC","BE","GIS","BSX","MRNA","INSP","CAG","MSFY","SJM","MSFO","BEG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627045446","title":"BUZZ--美国股票走势-Allogene Therapeutics、Adobe、Williams-Sonoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627045446","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627045446?lang=zh_cn&edition=fundamental","pubTime":"2026-04-13 23:45","pubTimestamp":1776095125,"startTime":"0","endTime":"0","summary":"nL6N40W0G6 ** Ocular Therapeutix Inc OCUL.O:BUZZ - 由于新眼药显示疾病控制时间更长而上涨 nL4N40W0TJ ** Spyre Therapeutics Inc SYRE.O:BUZZ - 因肠道疾病药物中期研究成功而上涨 nL6N40W0OH ** Alphabet Inc GOOGL.O：** Meta Platforms Inc META.O：** Snap Inc SNAP.N：** Pinterest Inc PINS.N：BUZZ - 因地缘政治动荡和能源价格，Stifel 下调数字广告增长预期 nL4N40W0RX ** ImageneBio Inc IMA.O:BUZZ--为资助脱发和皮肤病药物融资 3,000 万美元后股价上涨 nL4N40W0UI ** 国际商业机器公司IBM.N：BUZZ - 花旗集团开始对 IBM 进行 \"买入 \"评级。nL6N40W0O3 ** Best Buy Co Inc BBY.N:BUZZ - 因高盛将其评级双双下调至 \"卖出 \"而下滑。nL6N40W0RY ** Revolution Medicines Inc RVMD.O:BUZZ - 因胰腺癌药物","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4T40W1DN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOOGL","HPE","LYB","HUT","OWL","META","BBY","DIOD","REPL","HL","RVMD","COIN","MARA","BIIB","XOM","IBM","LUV","CAG","AAL","DAL","ADBE","EMN","CRWV","RIOT","IMA","NEM","CDE","ANIP","APTV","SBUX","CVX","OCUL","TFX","SYRE","UAL","DVN","HTFL","ALLO","DOW","AVT","SNDK","GGLS","LEG","KYMR","WSM","OXY","PINS","IDYA","GPRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179626267","title":"IDEAYA Biosciences飙涨逾40%！因眼癌药物组合试验达到主要目标并计划提交新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1179626267","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179626267?lang=zh_cn&edition=fundamental","pubTime":"2026-04-13 18:38","pubTimestamp":1776076736,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences今日盘前股价大幅上涨31.15%，引起了市场的广泛关注。独立中心影像评估确认，该组合疗法在主要疗效指标——中位无进展生存期方面展现出具有统计学意义的显著改善。具体数据显示，联合治疗组的中位生存期提高了6.9个月，而对照组仅为3.1个月，并且观察到了完全缓解病例。基于这些积极数据，公司计划在2026年下半年向美国食品药品监督管理局提交新药申请，寻求加速批准路径。","market":"nz","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"IDEAYA Biosciences飙涨逾40%！因眼癌药物组合试验达到主要目标并计划提交新药申请","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431105","title":"BUZZ-眼癌药物组合在试验中提高了存活率，IDEAYA 生物科学公司股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431105","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627431105?lang=zh_cn&edition=fundamental","pubTime":"2026-04-13 18:19","pubTimestamp":1776075570,"startTime":"0","endTime":"0","summary":"** 截至上一交易日收盘，IDYA股价累计下跌11.8%。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4S40W0O0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","BK4550","LU0456855351.SGD","LU1894683264.USD","LU1066053197.SGD","BK4534","BK4568","LU1894683348.USD","SG9999002224.SGD","LU0289739699.SGD","LU1066051498.USD","BK4588","LU0225284248.USD","LU0321505439.SGD","LU0321505868.SGD","LU0234572021.USD","LU1057294990.SGD","BK4007","BK4599","SG9999013999.USD","SG9999011175.SGD","IE00B19Z3581.USD","SGXZ57979304.SGD","LU0122379950.USD","IE00BLSP4239.USD","IDYA","SG9999003800.SGD","LU0306806265.USD","SG9999001176.SGD","IE0002270589.USD","LU0170899867.USD","IE000M9KFDE8.USD","LU0058720904.USD","LU1023059063.AUD","LU0985481810.HKD","BK4581","IE00B19Z3B42.SGD","BK4592","BK4585","IE00BLSP4452.SGD","SG9999002232.USD","LU1883839398.USD","LU0306807586.USD","LU0868494617.USD","IE00BBT3K403.USD","SG9999001176.USD","BK4533","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178706059","title":"IDEAYA与施维雅公布Darovasertib联合克唑替尼一线治疗HLA-A*02:01阴性转移性葡萄膜黑色素瘤的2/3期注册试验（OPTIMUM-02）积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1178706059","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178706059?lang=zh_cn&edition=fundamental","pubTime":"2026-04-13 18:07","pubTimestamp":1776074841,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences与施维雅联合宣布，其针对Darovasertib与克唑替尼组合疗法用于一线治疗HLA-A*02:01阴性转移性葡萄膜黑色素瘤的2/3期注册临床试验（OPTIMUM-02）取得积极顶线结果。该突破性进展标志着转移性葡萄膜黑色素瘤治疗领域迈出关键一步，为缺乏HLA-A*02:01基因型的患者群体提供了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431352","title":"Ideaya眼癌药物达到中后期试验的主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431352","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627431352?lang=zh_cn&edition=fundamental","pubTime":"2026-04-13 18:05","pubTimestamp":1776074710,"startTime":"0","endTime":"0","summary":"Ideaya眼癌药物达到中后期试验的主要目标路透4月13日 - Ideaya Biosciences IDYA.O周一表示，其治疗一种眼癌的药物达到了中后期试验的主要目标，患者的生存率得到了改善，且疾病未进展。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4S40W0MT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100785826","title":"IDEAYA Biosciences计划于2026年下半年提交新药申请 支持美国加速审批路径","url":"https://stock-news.laohu8.com/highlight/detail?id=1100785826","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100785826?lang=zh_cn&edition=fundamental","pubTime":"2026-04-13 18:01","pubTimestamp":1776074476,"startTime":"0","endTime":"0","summary":"生物制药公司IDEAYA Biosciences宣布，其针对关键研发项目的新药申请（NDA）时间表已正式确立——公司计划在2026年下半年向美国食品药品监督管理局（FDA）提交申报材料，旨在通过加速审批通道推动创新疗法早日上市。\n这一战略部署凸显了IDEAYA在肿瘤靶向治疗领域的研发进展与监管策略的协同推进。若获批，加速审批机制将显著缩短药物从临床验证到商业化的周期，为存在未满足医疗需求的患者提供更及时的治疗选择。\n公司管理层表示，此次NDA提交计划基于现有临床数据包的积极结果与后续试验设计，具体申报范围将随研发里程碑的达成而进一步明确。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175431474","title":"IDEAYA Biosciences临床试验达到主要终点 BICR评估显示中位无进展生存期实现统计学显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1175431474","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175431474?lang=zh_cn&edition=fundamental","pubTime":"2026-04-13 18:01","pubTimestamp":1776074474,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences宣布其临床试验成功达到主要研究终点。经独立中心影像评估确认，该研究在主要疗效指标——中位无进展生存期方面展现出具有统计学意义的显著改善。\n这一突破性进展标志着公司在靶向疗法开发领域取得重要里程碑，为后续临床开发计划的推进奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}